Insulin resistance in brain alters dopamine turnover and causes behavioral disorders
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Significance: Both types 1 and 2 diabetes are associated with increased risks of age-related decay in cognitive function and mood disorders, especially depression. Insulin action has been shown to regulate neuronal signaling and plasticity. Here we investigate whether brain-specific knockout of insulin receptor (NIRKO) in mice causes behavioral changes and how these are mechanistically linked. We find that NIRKO mice exhibit age-related anxiety and depressive-like behavior. This is due to altered mitochondrial function, aberrant monoamine oxidase (MAO) expression, and increased dopamine turnover in the mesolimbic system, and can be reversed by treatment with Mao inhibitors. Thus, brain insulin resistance alters dopamine turnover and induces anxiety and depressive-like behaviors. These findings demonstrate a potential molecular link between central insulin resistance and behavioral disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IR deletion in muscle, heart, and brain decreases mitochondrial respiration and increases oxidative stress (35)(36)(37).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [37]
Citations
Cites
Cellular Scaling Rules for the Brains of Marsupials: Not as “Primitive” as Expected
Dos Santos, S. E., Porfirio, J., da Cunha, F. B., Manger, P. R., Tavares, W., Pessoa, L., Raghanti, M. A., Sherwood, C. C., & Herculano-Houzel, S. (2017) · Brain, Behavior and Evolution · doi:10.1159/000452856 · Cited by 2,642
Role of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Self-citationPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Self-citationTalbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871 · cited 1×
“Conversely, patients with Alzheimer’s disease show signs of central insulin resistance with increased insulin receptor substrate (IRS) 1 serine phosphorylation in the brain and decreased insulin concentrations in the cerebrospinal fluid (9, 10).”
BackgroundObesity is associated with hypothalamic injury in rodents and humans.
Thaler, J. P., Yi, C.-X., Schur, E. A., Guyenet, S. J., Hwang, B. H., Dietrich, M. O., Zhao, X., Sarruf, D. A., Izgur, V., Maravilla, K. R., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59660 · Cited by 1,857
Depression and Type 2 Diabetes Over the Lifespan
Mezuk, B., Eaton, W. W., Albrecht, S., & Golden, S. H. (2008) · Diabetes Care · doi:10.2337/dc08-0985 · Cited by 1,558
Craft, S. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.233 · Cited by 1,253
Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons
Chaudhury, D., Walsh, J. J., Friedman, A. K., Juarez, B., Ku, S. M., Koo, J. W., Ferguson, D., Tsai, H.-C., Pomeranz, L., Christoffel, D. J., et al. (2013) · Nature · doi:10.1038/nature11713 · Cited by 1,156 · cited 1×
“Dopamine signaling in the striatum and mesolimbic system has been shown to be particularly important in depression (32, 33).”
BackgroundDopamine neurons modulate neural encoding and expression of depression-related behaviour
Tye, K. M., Mirzabekov, J. J., Warden, M. R., Ferenczi, E. A., Tsai, H.-C., Finkelstein, J., Kim, S.-Y., Adhikari, A., Thompson, K. R., Andalman, A. S., et al. (2013) · Nature · doi:10.1038/nature11740 · Cited by 1,073 · cited 1×
“Dopamine signaling in the striatum and mesolimbic system has been shown to be particularly important in depression (32, 33).”
BackgroundBomfim, T. R., Forny-Germano, L., Sathler, L. B., Brito-Moreira, J., Houzel, J.-C., Decker, H., Silverman, M. A., Kazi, H., Melo, H. M., McClean, P. L., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57256 · Cited by 832
Cognitive Dysfunction and Diabetes Mellitus
Kodl, C. T., & Seaquist, E. R. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0034 · Cited by 802
Mitochondria, oxidative stress and neurodegeneration
Federico, A., Cardaioli, E., Da Pozzo, P., Formichi, P., Gallus, G. N., & Radi, E. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.05.030 · Cited by 787
Herculano‐Houzel, S. (2014) · Glia · doi:10.1002/glia.22683 · Cited by 731 · cited 1×
“This may suggest that discrete compartments in the brain differ in their response to insulin (53), or that different cellular compositions in discrete brain areas result in different effects of insulin resistance (54).”
BackgroundDe Felice, F. G., & Ferreira, S. T. (2014) · Diabetes · doi:10.2337/db13-1954 · Cited by 639
Role for neuronal insulin resistance in neurodegenerative diseases
Schubert, M., Gautam, D., Surjo, D., Ueki, K., Baudler, S., Schubert, D., Kondo, T., Alber, J., Galldiks, N., Küstermann, E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308724101 · Cited by 637
Self-citationMonoamine oxidase inactivation: from pathophysiology to therapeutics
Bortolato, M., Chen, K., & Shih, J. C. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.06.002 · Cited by 634
Insulin Action in Brain Regulates Systemic Metabolism and Brain Function
Kleinridders, A., Ferris, H. A., Cai, W., & Kahn, C. R. (2014) · Diabetes · doi:10.2337/db14-0568 · Cited by 625
Self-citationMeyer, J. H., Ginovart, N., Boovariwala, A., Sagrati, S., Hussey, D., Garcia, A., Young, T., Praschak-Rieder, N., Wilson, A. A., & Houle, S. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1209 · Cited by 585
Mitofusin 2 in POMC neurons connects ER stress with leptin resistance and energy imbalance
Schneeberger, M., Dietrich, M. O., Sebastián, D., Imbernón, M., Castaño, C., Garcia, A., Esteban, Y., Gonzalez-Franquesa, A., Rodríguez, I. C., Bortolozzi, A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.003 · Cited by 519
Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI
den Heijer, T., Vermeer, S. E., van Dijk, E. J., Prins, N. D., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2003) · Diabetologia · doi:10.1007/s00125-003-1235-0 · Cited by 514
Insulin Activation of Phosphatidylinositol 3-Kinase in the Hypothalamic Arcuate Nucleus
Niswender, K. D., Morrison, C. D., Clegg, D. J., Olson, R., Baskin, D. G., Myers, M. G., Seeley, R. J., & Schwartz, M. W. (2003) · Diabetes · doi:10.2337/diabetes.52.2.227 · Cited by 476
Mitochondrial Dysfunction and Psychiatric Disorders
Rezin, G. T., Amboni, G., Zugno, A. I., Quevedo, J., & Streck, E. L. (2009) · Neurochemical Research · doi:10.1007/s11064-008-9865-8 · Cited by 442
Central insulin action in energy and glucose homeostasis
Plum, L. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29063 · Cited by 437
Chiu, S.-L., Chen, C.-M., & Cline, H. T. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.014 · Cited by 425
Deficits of mesolimbic dopamine neurotransmission in rat dietary obesity
Geiger, B. M., Haburcak, M., Avena, N. M., Moyer, M. C., Hoebel, B. G., & Pothos, E. N. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.02.007 · Cited by 403
Self-citationHeninger, G., Delgado, P., & Charney, D. (1996) · Pharmacopsychiatry · doi:10.1055/s-2007-979535 · Cited by 380
A systematic look at an old problem
Kirkwood, T. B. L. (2008) · Nature · doi:10.1038/451644a · Cited by 363
Gardner, A., & Boles, R. G. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.030 · Cited by 333 · cited 1×
“Patients with major depression have also been shown to exhibit mitochondrial dysfunction in the brain (37).”
BackgroundDopamine is a monoamine oxidase B substrate in man
GLOVER, V., SANDLER, M., OWEN, F., & RILEY, G. J. (1977) · Nature · doi:10.1038/265080a0 · Cited by 324
Selective Insulin and Leptin Resistance in Metabolic Disorders
Könner, A. C., & Brüning, J. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.004 · Cited by 303
Zhang, D., Liu, Z.-X., Choi, C. S., Tian, L., Kibbey, R., Dong, J., Cline, G. W., Wood, P. A., & Shulman, G. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707060104 · Cited by 291 · cited 1×
“Insulin resistance and type 2 diabetes are well documented to be associated with mitochondrial dysfunction in classical metabolic tissues, such as muscle (34) and liver (35), and we have recently demonstrated that obesity-induced insulin resistance is also associated with altered mitochondrial function in the hypothal…”
BackgroundDiabetes and Risk of Parkinson’s Disease
Xu, Q., Park, Y., Huang, X., Hollenbeck, A., Blair, A., Schatzkin, A., & Chen, H. (2011) · Diabetes Care · doi:10.2337/dc10-1922 · Cited by 271
Diano, S., Liu, Z.-W., Jeong, J. K., Dietrich, M. O., Ruan, H.-B., Kim, E., Suyama, S., Kelly, K., Gyengesi, E., Arbiser, J. L., et al. (2011) · Nature Medicine · doi:10.1038/nm.2421 · Cited by 267
Depression and type 2 diabetes: Inflammatory mechanisms of a psychoneuroendocrine co-morbidity
Stuart, M. J., & Baune, B. T. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.10.001 · Cited by 257
The Relationship Between Diabetes Mellitus and Parkinson'S Disease
Sandyk, R. (1993) · International Journal of Neuroscience · doi:10.3109/00207459309003322 · Cited by 243
Resting-State Brain Functional Connectivity Is Altered in Type 2 Diabetes
Musen, G., Jacobson, A. M., Bolo, N. R., Simonson, D. C., Shenton, M. E., McCartney, R. L., Flores, V. L., & Hoogenboom, W. S. (2012) · Diabetes · doi:10.2337/db11-1669 · Cited by 242
High-fat feeding promotes obesity via insulin receptor/PI3K-dependent inhibition of SF-1 VMH neurons
Klöckener, T., Hess, S., Belgardt, B. F., Paeger, L., Verhagen, L. A. W., Husch, A., Sohn, J.-W., Hampel, B., Dhillon, H., Zigman, J. M., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2847 · Cited by 239
Perona, M. T. G., Waters, S., Hall, F. S., Sora, I., Lesch, K.-P., Murphy, D. L., Caron, M., & Uhl, G. R. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830cd80f · Cited by 201
The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson’s disease
Hastings, T. G. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9257-z · Cited by 199 · cited 1×
“It is interesting to note that despite the alterations in brain mitochondrial function in the NIRKO mouse, the resulting mitochondrial stress does not induce a proinflammatory response or measurable signs of apoptosis, even in a prooxidative dopaminergic system (56).”
BackgroundAnthony (2006) · doi:10.2337/db06-0376 · Cited by 195
Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis
Könner, A. C., Hess, S., Tovar, S., Mesaros, A., Sánchez-Lasheras, C., Evers, N., Verhagen, L. A. W., Brönneke, H. S., Kleinridders, A., Hampel, B., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.021 · Cited by 194 · cited 2×
“Furthermore, ablation of insulin receptor in catecholaminergic neurons attenuates insulin-induced excitability in dopaminergic neurons (29), whereas insulin administration into the central nervous system (CNS) of rats has been shown to increase dopamine transporter protein expression (30).”
BackgroundResultSelf-citationNeurobehavioral deficits in db/db diabetic mice
Sharma, A. N., Elased, K. M., Garrett, T. L., & Lucot, J. B. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.07.002 · Cited by 179
Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra
Figlewicz, D. P., Szot, P., Chavez, M., Woods, S. C., & Veith, R. C. (1994) · Brain Research · doi:10.1016/0006-8993(94)91698-5 · Cited by 172
Striatal dopamine transporter density in major depression
Laasonen-Balk, T., Kuikka, J., Viinam�ki, H., Husso-Saastamoinen, M., Lehtonen, J., & Tiihonen, J. (1999) · Psychopharmacology · doi:10.1007/s002130051005 · Cited by 172
Insulin action in the brain contributes to glucose lowering during insulin treatment of diabetes
Gelling, R. W., Morton, G. J., Morrison, C. D., Niswender, K. D., Myers, M. G., Rhodes, C. J., & Schwartz, M. W. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2005.11.013 · Cited by 169
Modulation of food reward by adiposity signals
Figlewicz, D. P., Naleid, A. M., & Sipols, A. J. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.10.008 · Cited by 163
A Disturbance in the Neuronal Insulin Receptor Signal Transduction in Sporadic Alzheimer's Disease
FRÖLICH, L., BLUM‐DEGEN, D., RIEDERER, P., & HOYER, S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07839.x · Cited by 160
Preferential deamination of dopamine by an A type monoamine oxidase in rat brain
Waldmeier, P. C., Delini‐Stula, A., & Ma�tre, L. (1976) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00506483 · Cited by 139
Hoogenboom, W. S., Marder, T. J., Flores, V. L., Huisman, S., Eaton, H. P., Schneiderman, J. S., Bolo, N. R., Simonson, D. C., Jacobson, A. M., Kubicki, M., et al. (2014) · Diabetes · doi:10.2337/db13-1219 · Cited by 138
Villeneuve, C., Guilbeau-Frugier, C., Sicard, P., Lairez, O., Ordener, C., Duparc, T., De Paulis, D., Couderc, B., Spreux-Varoquaux, O., Tortosa, F., et al. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4373 · Cited by 134
Leptin regulation of Hsp60 impacts hypothalamic insulin signaling
Kleinridders, A., Lauritzen, H. P. M. M., Ussar, S., Christensen, J. H., Mori, M. A., Bross, P., & Kahn, C. R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67615 · Cited by 130 · cited 2×
“It has been shown that insulin resistance in the brain (36), like insulin resistance in skeletal muscle (34), is associated with mitochondrial dysfunction, and mitochondrial dysfunction has been associated with neurological disorders (41).”
BackgroundSelf-citationChou, C.-H., Lin, C.-C., Yang, M.-C., Wei, C.-C., Liao, H.-D., Lin, R.-C., Tu, W.-Y., Kao, T.-C., Hsu, C.-M., Cheng, J.-T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049112 · Cited by 124
Fisher, S. J., Brüning, J. C., Lannon, S., & Kahn, C. R. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1447 · Cited by 115
Self-citationHarmine and Imipramine Promote Antioxidant Activities in Prefrontal Cortex and Hippocampus
Réus, G. Z., Stringari, R. B., de Souza, B., Petronilho, F., Dal-Pizzol, F., Hallak, J. E., Zuardi, A. W., Crippa, J. A., & Quevedo, J. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.5.13109 · Cited by 110 · cited 1×
“To further explore the relationship between the depressive-like behavior, mitochondrial dysfunction, and altered dopamine signaling in NIRKO mice, we subjected these mice to treatment with the antidepressant imipramine, which has been shown to target MAO A and B, as well as reduce oxidative stress secondary to mitocho…”
MethodDepression and antidepressants: molecular and cellular aspects
Lanni, C., Govoni, S. M., Lucchelli, A., & Boselli, C. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0055-x · Cited by 107
IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease
Sadagurski, M., Cheng, Z., Rozzo, A., Palazzolo, I., Kelley, G. R., Dong, X., Krainc, D., & White, M. F. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46305 · Cited by 107 · cited 1×
“On the other hand, knockout of IRS-2 has been shown to have protective effects on brain pathology in a mouse model of Huntington’s disease (23).”
BackgroundRegulation of insect behavior via the insulin-signaling pathway
Erion, R., & Sehgal, A. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00353 · Cited by 90
Hypothalamic Astrocytes in Obesity
García‐Cáceres, C., Yi, C., & Tschöp, M. H. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.11.003 · Cited by 87
Bolo, N. R., Musen, G., Jacobson, A. M., Weinger, K., McCartney, R. L., Flores, V., Renshaw, P. F., & Simonson, D. C. (2011) · Diabetes · doi:10.2337/db11-0506 · Cited by 72 · cited 2×
“6. den Heijer T, et al. (2003) Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI.”
BackgroundA Neural Circuitry Linking Insulin Resistance to Depressed Mood
Ryan, J. P., Sheu, L. K., Critchley, H. D., & Gianaros, P. J. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31824d0865 · Cited by 68 · cited 1×
“In addition, individuals with both type 1 and type 2 diabetes have been shown to have a variety of abnormalities in brain imaging, including altered brain activity and connectivity by functional MRI (4, 5), altered microstructure by diffusion tensor imaging (6, 7), and altered neuronal circuitry in the striatum (8).”
BackgroundRosiglitazone treatment reversed depression- but not psychosis-like behavior of db/db diabetic mice
Sharma, A. N., Elased, K. M., & Lucot, J. B. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111434620 · Cited by 59
Cytochrome c Is Tyrosine 97 Phosphorylated by Neuroprotective Insulin Treatment
Sanderson, T. H., Mahapatra, G., Pecina, P., Ji, Q., Yu, K., Sinkler, C. A., Varughese, A., Kumar, R., Bukowski, M. J., Tousignant, R. N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078627 · Cited by 58
Dlugos, A. M., Palmer, A. A., & de Wit, H. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0281-2 · Cited by 40
Nag, M. (2004) · PubMed · Cited by 8
Cited by
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750
The menace of obesity to depression and anxiety prevalence
Fulton, S., Décarie-Spain, L., Fioramonti, X., Guiard, B., & Nakajima, S. (2022) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2021.10.005 · Cited by 441
“Deletion of insulin receptor in neurons or astrocytes was shown to promote the development of anxiety- and depressive-like symptoms [103,127].”
BackgroundAthauda, D., & Foltynie, T. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.013 · Cited by 383
“38, 806–816 201 Kleinridders, A. et al. (2015) Insulin resistance in brain alters dopamine turnover and causes behavioral disorders.”
BackgroundInsulin resistance and Parkinson’s disease: A new target for disease modification?
Athauda, D., & Foltynie, T. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.10.001 · Cited by 328
Michailidis, M., Moraitou, D., Tata, D. A., Kalinderi, K., Papamitsou, T., & Papaliagkas, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052687 · Cited by 330
Metadata
- Authors
- Kleinridders, A., Cai, W., Cappellucci, L., Ghazarian, A., Collins, W. R., Vienberg, S. G., Pothos, E. N., & Kahn, C. R.
- Affiliations
- Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215; and
- Joslin Diabetes Center (US)
- Department of Integrative Physiology and Pathobiology and
- Tufts University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2015-03-02
- Volume
- 112
- Issue
- 11
- Pages
- 3463-3468
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4371978
- OpenAlex
- W2040181124
- Cited by
- 486
- References
- 64
- Citations by year
- 2026: 39 · 2025: 61 · 2024: 56 · 2023: 46 · 2022: 54 · 2021: 56 · 2020: 33 · 2019: 38 · 2018: 37 · 2017: 20 · 2016: 31 · 2015: 15
- FWCI
- 16.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- HHS | National Institutes of Health (R01 DK031036, P30 DK036836)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- brain insulin resistance, dopamine turnover, monoamine oxidase A, monoamine oxidase B, mitochondrial dysfunction, oxidative stress, lipid peroxidation, protein oxidation, striatum, nucleus accumbens, anxiety-like behavior, depression-like behavior, monoamine oxidase inhibitors, imipramine, tricyclic antidepressants, age-related cognitive impairment
- MeSH terms
- Aging, Animals, Antidepressive Agents, Anxiety, Behavior, Animal, Brain, Depression, Dopamine, Insulin Resistance, Mice, Inbred C57BL, Mitochondria, Receptor, Insulin, Signal Transduction, Mice, Knockout, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.